Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:focus |
neuropsychiatric disorders
depression treatment obsessive-compulsive disorder treatment |
| gptkbp:foundedBy |
Abraham Zangen
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:location |
gptkb:Israel
|
| gptkbp:product |
gptkb:Brainsway
|
| gptkbp:technology |
deep transcranial magnetic stimulation
|
| gptkbp:bfsParent |
gptkb:Bernadette_Rostenkowski-Wolowitz
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zangen Pharmaceuticals
|